以基因型为导向治疗改变了转移性非小细胞肺癌治疗模式

李娟, 张力建, 王跃辉, 朱步东 - Advances in Clinical Medicine, 2013 - hanspub.org
… The treatment mode changed from chemotherapy to the combining treatment of genotype-oriented
and chemotherapy. Meanwhile, the clinical researches of maintenance treatment, …

[引用][C] 呼吸科专皿

HP Liu, LH Li - 中国肺癌杂志, 2004

[PDF][PDF] 厄洛替尼治疗晚期非小细胞肺癌的系统评价

朱利娜, 杨振君, 王士勇, 汤燕明 - 中国肺癌杂志, 2009 - scholar.archive.org
… of this study is to review the effectiveness and safety of erlotinib for … clinical favor from erlotinib
combined chemotherapy remains uncertain. But the effect of erlotinib being used in clinical

[HTML][HTML] EGFR 敏感突变NSCLC 患者的最佳治疗模式探讨

史钟, 范云 - Chinese Journal of Lung Cancer, 2015 - ncbi.nlm.nih.gov
… about how to combine EGFR-TKI with chemotherapy and other targeted drugs. We have
made a summary on the current therapeutic models of EGFR-TKI combined with chemotherapy/…

[HTML][HTML] 消化系统肿瘤的分子靶向治疗

吴晴, 李兆申 - 世界华人消化杂志, 2008 - wjgnet.com
… 表皮生长因子受体-酪氨酸激酶(EGFR-TK)系统抑制剂OSI-774-埃罗替尼(erlotinib, tarceva)是
作用… Assessment of a HER2 scoring system for gastric cancer: results from a validation study. …

[HTML][HTML] 多西他赛与吉非替尼序贯应用对人肺腺癌细胞H1975 存活及凋亡通路的研究

张鑫宇, 刘皈阳, 祝晓光, 王伟兰 - Chinese Journal of Lung …, 2012 - ncbi.nlm.nih.gov
… as gefitinib and erlotinib show promising therapeutic effects in … patients in most studies is
around 50%. The aim of this … were determined by isobolograms and combination index (CI). …

EGFR 敏感突变的晚期肺腺癌一线化疗与吉非替尼联合治疗的随机对照研究

金波, 张岩巍, 韩宝惠 - 中国癌症杂志, 2015 - china-oncology.com
… mutant lung adenocarcinoma, combination of chemotherapy with … Afatinib versus cisplatin
plus gemcitabine for first-line … -label phasetrial of sequential erlotinib and gemcitabine

[PDF][PDF] 厄洛替尼治疗非小细胞肺癌并发贫血的Meta 分析

马虎, 周建国, 柏玉举, 张钰, 王菲, 王怡… - 中华肿瘤防治 …, 2016 - researchgate.net
RESULTS A total of 17RCTs were included.The meta… erlotinib in combination with cisplatin
and gemcitabine in ad… trial of erlotinib hydrochloride(OSI-774)combined with carboplatin and …

[PDF][PDF] 靶向治疗在非小细胞肺癌中的应用进展

张瑞秀, 赵永, 张占雀 - 2009 - core.ac.uk
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-…
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in …

[PDF][PDF] 血管内皮生长因子和表皮生长因子信号通路的联合抑制在非小细胞肺癌治疗中的应用

南娟, 刘谦, 丁燕, 张占雀, 周清华 - 中国肺癌杂志, 2009 - core.ac.uk
Phase III trial of cisplatin plus gemcitabine with either … bevacizumab in combination with
chemotherapy or erlotinib com… to EGFR-TKIs: preliminary results of a phase II trial. J Clin Oncol, …